Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Healthcare Services Nano (25.0mn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Nano (24.9mn) 0 No activity — 0–15%
Healthcare Services Nano (24.8mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (24.7mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (24.6mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (24.5mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (24.3mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (24.3mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (24.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (23.9mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (23.8mn) 0 No activity — 15–50%
Healthcare Services Nano (23.4mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (23.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (23.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (23.3mn) 0 No activity — 15–50%
Healthcare Services Nano (23.2mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (22.9mn) 0 No activity — 15–50%
Healthcare Services Nano (22.8mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (22.8mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (22.6mn) 0 No activity — 15–50%
Healthcare Services Nano (22.6mn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Nano (22.6mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (22.5mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (22.3mn) 0 No activity — 0–15%
Healthcare Services Nano (22.3mn) 0 No activity — 15–50%
Healthcare Services Nano (22.2mn) 0 No activity — 15–50%
Healthcare Services Nano (22.1mn) 0 No activity — 15–50%
Healthcare Services Nano (22.1mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (21.8mn) 0 No activity — —
Pharmaceuticals & Medical Research Nano (21.7mn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Nano (21.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (21.6mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (21.6mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (21.5mn) 0 No activity — 0–15%
Healthcare Services Nano (21.4mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (21.4mn) 0 No activity — 15–50%
Healthcare Services Nano (21.4mn) 0 No activity — 0–15%
Healthcare Services Nano (21.2mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (21.1mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (21.0mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (20.9mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (20.9mn) 0 No activity — 50%+
Healthcare Services Nano (20.9mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (20.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (20.7mn) 0 No activity — 0–15%
Healthcare Services Nano (20.5mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (20.2mn) 0 No activity — 0–15%
Healthcare Services Nano (20.1mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (19.9mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (19.7mn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Nano (19.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (19.5mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (19.4mn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Nano (19.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (19.1mn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (18.9mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (18.9mn) 0 No activity — —
Pharmaceuticals & Medical Research Nano (18.5mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (18.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (18.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (18.2mn) 0 No activity — —
Pharmaceuticals & Medical Research Nano (18.1mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (18.1mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (18.0mn) 0 No activity — 0–15%
Healthcare Services Nano (17.9mn) 0 No activity — 0–15%
SE Irras AB (IRRAS)
Healthcare Services Nano (17.9mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (17.8mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (17.7mn) 0 No activity — 0–15%
Healthcare Services Nano (17.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (17.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (17.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (17.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (17.6mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (17.6mn) 0 No activity — 15–50%
Healthcare Services Nano (17.4mn) 0 No activity — 0–15%
Healthcare Services Nano (17.3mn) 0 No activity — 50%+
Healthcare Services Nano (17.3mn) 0 No activity — 50%+
Healthcare Services Nano (17.0mn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Nano (17.0mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (17.0mn) 0 No activity — 50%+
Healthcare Services Nano (16.9mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (16.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (16.5mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (16.5mn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Nano (16.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (16.4mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (16.1mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (16.1mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (16.1mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (16.0mn) 0 No activity — 15–50%
SE Ortivus AB (ORTI-B)
Healthcare Services Nano (16.0mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (15.9mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (15.8mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (15.8mn) 0 No activity — 0–15%
Healthcare Services Nano (15.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (15.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (15.7mn) 0 No activity — 15–50%
Healthcare Services Nano (15.7mn) 0 No activity — 50%+
Healthcare Services Nano (15.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (15.7mn) 0 No activity — 0–15%